{"id":"NCT01838551","sponsor":"Cortendo AB","briefTitle":"Treatment for Endogenous Cushing's Syndrome","officialTitle":"An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08","primaryCompletion":"2018-04","completion":"2018-11","firstPosted":"2013-04-24","resultsPosted":"2021-04-19","lastUpdate":"2021-04-19"},"enrollment":94,"design":{"allocation":"NON_RANDOMIZED","model":"SEQUENTIAL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Endogenous Cushing's Syndrome"],"interventions":[{"type":"DRUG","name":"Levoketoconazole","otherNames":["COR-003"]}],"arms":[{"label":"Levoketoconazole DL0","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL1","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL2","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL3","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL4","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL5","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL6","type":"EXPERIMENTAL"},{"label":"Levoketoconazole DL7","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to evaluate the clinical responder rate, defined as the proportion of subjects with normal UFC after 6 months of treatment with COR-003 in the Maintenance Phase without dose increase, and to evaluate the range of effective doses in subjects with various levels of hypercortisolism.","primaryOutcome":{"measure":"Normalization in Urinary Free Cortisol in Patients With Endogenous Cushing's Syndrome.","timeFrame":"6 months of maintenance phase therapy without a prior dose increase during that phase","effectByArm":[{"arm":"Levoketoconazole All Doses","deltaMin":0.3,"sd":null}],"pValues":[{"comp":"OG000","p":"0.0154"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":42,"countries":["United States","Belgium","Bulgaria","Canada","Czechia","Denmark","France","Germany","Israel","Italy","Netherlands","Poland","Serbia","Spain","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["31542384","33216275","33897615"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":94},"commonTop":["Nausea","Headache","Edema peripheral","Hypertension","Fatigue"]}}